REGENXBIO, Inc. (RGNX)
7.17
-0.23
(-3.11%)
USD |
NASDAQ |
Oct 21, 16:00
7.175
0.00 (0.00%)
After-Hours: 20:00
REGENXBIO Net Income (Annual) : -193.88M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -193.88M |
| December 31, 2024 | -227.10M |
| December 31, 2023 | -263.49M |
| December 31, 2022 | -280.32M |
| December 31, 2021 | 127.84M |
| December 31, 2020 | -111.25M |
| December 31, 2019 | -94.73M |
| Date | Value |
|---|---|
| December 31, 2018 | 99.94M |
| December 31, 2017 | -73.17M |
| December 31, 2016 | -62.97M |
| December 31, 2015 | -22.81M |
| December 31, 2014 | -4.003M |
| December 31, 2013 | -5.387M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| AbbVie, Inc. | 4.193B |
| United Therapeutics Corp. | 1.335B |
| Ardelyx, Inc. | -61.60M |
| Biomea Fusion, Inc. | -61.80M |
| RenovoRx, Inc. | -11.17M |